|
home
|
corporate
|
investors
|
products
|
clinical trials
|
partnering
|
contact
TSX: HBP
-
NYSE Amex: HBP
-
Frankfurt: HBP
Management Team
|
Corporate Profile
|
Management Team
|
Board of Directors
|
Medical Advisors
|
Media
|
Media Coverage
|
Publications
|
Contact
|
Investor Fact Sheet
Management Team
William White
Interim CEO
John M. Docherty, M.Sc.
President and COO
Frank Michalargias, CA
Chief Financial Officer
Heman Chao, Ph.D.
Chief Scientific Officer
